Financials
Income statement
Fiscal date | Aug 2025 | May 2025 | Feb 2025 | Nov 2024 |
---|---|---|---|---|
Total reported revenue | — | 8.0B | 6.9B | 7.5B |
Cost of revenue | — | 5.0B | 4.4B | 4.6B |
Gross profit | — | 3.0B | 2.5B | 2.9B |
Operating expense | ||||
Research & development | — | 827.6M | 770.1M | 761.5M |
Selling general and admin | — | 272.7M | 244.4M | 247.0M |
Other operating expenses | — | 48.0M | 6.0M | -1.7M |
Operating income | — | 1.9B | 1.5B | 1.9B |
Non operating interest income | ||||
Income | — | 115.8M | 92.6M | 91.8M |
Expense | — | 105.5M | 96.1M | 101.2M |
Other income expense | — | -58.3M | -9.4M | -9.4M |
Pretax income | — | 1.8B | 1.5B | 1.8B |
Tax provision | — | 201.5M | 151.8M | 242.7M |
Net income | — | 1.6B | 1.4B | 1.6B |
Basic EPS | 2.9 | 1.7 | 1.4 | 1.7 |
Diluted EPS | 2.8 | 1.7 | 1.4 | 1.7 |
Basic average shares | 960.5M | 958.8M | 956.2M | 952.8M |
Diluted average shares | 969.9M | 964.8M | 963.1M | 962.2M |
EBITDA | — | 3.7B | 3.4B | 3.7B |
Net income from continuing op. | — | 1.6B | 1.4B | 1.6B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |